Great new solution from our portfolio company GYANT!
Anticipating the tsunami of inbound patient inquiries, overwhelmed call centers, appointment scheduling demands, and eligibility screening requests as the vaccine becomes available, GYANT Vaccine will virtually guide patients through the entire pre- and post-vaccination process.
“Navigating the deployment of the COVID-19 vaccine will be the single biggest challenge healthcare systems face in 2021,” said Stefan Behrens, co-founder and chief executive officer, GYANT.
FOLLOW ALPANA NEWS:
SWITZERLAND
Tour de l’Ile 1
CH – 1204 Geneva
+41 22 312 20 50
SILICON VALLEY, USA
Via Regina
Saratoga CA 95070
+1 408 644 8104
Copyright 2021 by ALPANA VENTURES